PDCD1 and disease arising from reactivation of latent virus: Moreover, it was demonstrated that the PD-1 monoclonal antibody (pembrolizumab) can significantly upregulate HIV-1 LTR transcription, suggesting that PD-1 not only contributes to immune escape during HIV infection but may also promote the persistence of latent infection [24].